FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q35535221> ?p ?o ?g. }

• Q35535221 description "2015 nî lūn-bûn" @default.
• Q35535221 description "2015 թուականի Մայիսին հրատարակուած գիտական յօդուած" @default.
• Q35535221 description "2015 թվականի մայիսին հրատարակված գիտական հոդված" @default.
• Q35535221 description "2015年の論文" @default.
• Q35535221 description "2015年論文" @default.
• Q35535221 description "2015年論文" @default.
• Q35535221 description "2015年論文" @default.
• Q35535221 description "2015年論文" @default.
• Q35535221 description "2015年論文" @default.
• Q35535221 description "2015年论文" @default.
• Q35535221 description "2015年论文" @default.
• Q35535221 description "2015年论文" @default.
• Q35535221 description "2015年论文" @default.
• Q35535221 description "2015年论文" @default.
• Q35535221 description "2015年论文" @default.
• Q35535221 description "2015년 논문" @default.
• Q35535221 description "article científic" @default.
• Q35535221 description "article scientific" @default.
• Q35535221 description "article scientifique" @default.
• Q35535221 description "articol științific" @default.
• Q35535221 description "articolo scientifico" @default.
• Q35535221 description "artigo científico" @default.
• Q35535221 description "artigo científico" @default.
• Q35535221 description "artigo científico" @default.
• Q35535221 description "artikel ilmiah" @default.
• Q35535221 description "artikull shkencor" @default.
• Q35535221 description "artikulong pang-agham" @default.
• Q35535221 description "artykuł naukowy" @default.
• Q35535221 description "artículo científico publicado en 2015" @default.
• Q35535221 description "artículu científicu espublizáu en 2015" @default.
• Q35535221 description "bilimsel makale" @default.
• Q35535221 description "bài báo khoa học" @default.
• Q35535221 description "mokslinis straipsnis" @default.
• Q35535221 description "naučni članak" @default.
• Q35535221 description "scienca artikolo" @default.
• Q35535221 description "scientific article published on May 2015" @default.
• Q35535221 description "scientific article published on May 2015" @default.
• Q35535221 description "scientific article published on May 2015" @default.
• Q35535221 description "teaduslik artikkel" @default.
• Q35535221 description "tieteellinen artikkeli" @default.
• Q35535221 description "tudományos cikk" @default.
• Q35535221 description "vedecký článok" @default.
• Q35535221 description "vetenskaplig artikel" @default.
• Q35535221 description "videnskabelig artikel" @default.
• Q35535221 description "vitenskapelig artikkel" @default.
• Q35535221 description "vitskapeleg artikkel" @default.
• Q35535221 description "vědecký článek" @default.
• Q35535221 description "wetenschappelijk artikel" @default.
• Q35535221 description "wissenschaftlicher Artikel" @default.
• Q35535221 description "επιστημονικό άρθρο" @default.
• Q35535221 description "мақолаи илмӣ" @default.
• Q35535221 description "мақолаи илмӣ" @default.
• Q35535221 description "наукова стаття, опублікована в травні 2015" @default.
• Q35535221 description "научна статия" @default.
• Q35535221 description "научная статья" @default.
• Q35535221 description "научни чланак" @default.
• Q35535221 description "научни чланак" @default.
• Q35535221 description "מאמר מדעי" @default.
• Q35535221 description "مقالة علمية نشرت في مايو 2015" @default.
• Q35535221 description "মে ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q35535221 description "บทความทางวิทยาศาสตร์" @default.
• Q35535221 description "სამეცნიერო სტატია" @default.
• Q35535221 name "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 name "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 name "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 type Item @default.
• Q35535221 label "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 label "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 label "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 prefLabel "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 prefLabel "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 prefLabel "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 P1433 Q35535221-6A6F0438-FED4-4106-8CBB-24E083A2A0AF @default.
• Q35535221 P1476 Q35535221-7F758ECF-544F-4F71-80F1-91257913914D @default.
• Q35535221 P2093 Q35535221-5EF41D8D-8695-48D1-A522-DA5F6E9EFCAB @default.
• Q35535221 P2093 Q35535221-7E3C8807-A135-4003-A0B4-945878593852 @default.
• Q35535221 P2093 Q35535221-BA49BC82-21F7-4F01-A611-17E365ADCA92 @default.
• Q35535221 P2860 Q35535221-1809FC8A-052C-42B7-8121-315DCB0C9999 @default.
• Q35535221 P2860 Q35535221-20B4D81C-83B0-4B1C-A829-B279C9EB37B7 @default.
• Q35535221 P2860 Q35535221-4FA851BD-92FF-4ACE-AD08-71917D5E55DE @default.
• Q35535221 P304 Q35535221-7439F891-E323-4189-8125-29B6D88D2D45 @default.
• Q35535221 P31 Q35535221-87500B78-73C1-4476-8FD2-A46C44215C62 @default.
• Q35535221 P356 Q35535221-94DB3AB4-FE96-4D82-A4E6-6A69A8EF8D58 @default.
• Q35535221 P433 Q35535221-B9121C73-3D13-42EF-871A-3650CD56CDC7 @default.
• Q35535221 P478 Q35535221-CBD11154-B26D-4EBF-BC9D-34325273CB50 @default.
• Q35535221 P577 Q35535221-951BF2CD-0BAC-4C2F-A8AD-96021516ED9A @default.
• Q35535221 P698 Q35535221-66EE8AE3-61E4-4942-85E6-E42EB102D668 @default.
• Q35535221 P921 Q35535221-052E7132-C9AF-4B46-8D39-06F366EB10EE @default.
• Q35535221 P921 Q35535221-2E641A6F-D219-4A69-A91F-B11B28932705 @default.
• Q35535221 P921 Q35535221-31E63F63-C574-41E5-BB25-1D6534B72F55 @default.
• Q35535221 P932 Q35535221-BAC8D3B5-5F66-4A74-82B4-5E713A22CF0B @default.
• Q35535221 P356 JTO.0000000000000448 @default.
• Q35535221 P698 25902175 @default.
• Q35535221 P1433 Q2448056 @default.
• Q35535221 P1476 "Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met-Amplified Adenocarcinoma of the Lung" @default.
• Q35535221 P2093 "Joan Hoff Schiller" @default.
• Q35535221 P2093 "Martin Frederik Dietrich" @default.
• Q35535221 P2093 "Shirley Xiao Yan" @default.
• Q35535221 P2860 Q27851406 @default.
• Q35535221 P2860 Q27851588 @default.

• next